Have a feature idea you'd love to see implemented?
Let us know!
APYX Apyx Medical Corp
Price (delayed)
$1.42
Market cap
$49.19M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.83
Enterprise value
$60.03M
Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people's lives through innovative products in the cosmetic and surgical markets. Known for its innovative Helium
Highlights
The quick ratio is up by 25% year-on-year
APYX's debt has soared by 170% YoY
The EPS has dropped by 93% year-on-year
Key stats
What are the main financial stats of APYX
Market
Valuations
Earnings
Shares outstanding
34.64M
Market cap
$49.19M
Enterprise value
$60.03M
Price to earnings (P/E)
N/A
Price to book (P/B)
4.46
Price to sales (P/S)
1.01
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.24
Revenue
$48.54M
EBIT
-$22.82M
EBITDA
-$22.1M
Free cash flow
-$17.89M
Per share
Balance sheet
Liquidity
EPS
-$0.83
Free cash flow per share
-$0.52
Book value per share
$0.32
Revenue per share
$1.4
TBVPS
$1.75
Total assets
$60.72M
Total liabilities
$49.52M
Debt
$38.85M
Equity
$11.04M
Working capital
$42.6M
Debt to equity
3.52
Current ratio
5.46
Quick ratio
4.3
Net debt/EBITDA
-0.49
Margins
Efficiency
Dividend
EBITDA margin
-45.5%
Gross margin
60.4%
Net margin
-58.6%
Operating margin
-44.4%
Return on assets
-41.2%
Return on equity
-156.4%
Return on invested capital
-37.2%
Return on capital employed
-44.6%
Return on sales
-47%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
APYX stock price
How has the Apyx Medical stock price performed over time
Intraday
1.43%
1 week
10.08%
1 month
21.37%
1 year
-40.34%
YTD
-45.8%
QTD
14.52%
Financial performance
How have Apyx Medical's revenue and profit performed over time
Revenue
$48.54M
Gross profit
$29.33M
Operating income
-$21.57M
Net income
-$28.44M
Gross margin
60.4%
Net margin
-58.6%
APYX's net margin has shrunk by 95% YoY
APYX's net income has dropped by 88% year-on-year
Apyx Medical's gross profit has decreased by 11% YoY and by 3.4% QoQ
Apyx Medical's operating margin has decreased by 11% YoY but it has increased by 3.5% QoQ
Growth
What is Apyx Medical's growth rate over time
Valuation
What is Apyx Medical stock price valuation
P/E
N/A
P/B
4.46
P/S
1.01
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.24
The EPS has dropped by 93% year-on-year
APYX's equity has dropped by 67% year-on-year and by 25% since the previous quarter
The price to book (P/B) is 37% higher than the last 4 quarters average of 3.2 and 7% higher than the 5-year quarterly average of 4.1
The stock's price to sales (P/S) is 81% less than its 5-year quarterly average of 5.2 and 9% less than its last 4 quarters average of 1.1
The revenue has declined by 3.5% year-on-year
Efficiency
How efficient is Apyx Medical business performance
The company's return on assets has shrunk by 57% YoY
The return on sales has declined by 46% year-on-year but it rose by 3.9% since the previous quarter
Apyx Medical's return on equity has decreased by 31% QoQ
The return on invested capital is up by 18% year-on-year and by 13% since the previous quarter
Dividends
What is APYX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for APYX.
Financial health
How did Apyx Medical financials performed over time
The total assets is 23% more than the total liabilities
Apyx Medical's total liabilities has surged by 92% YoY
The quick ratio is up by 25% year-on-year
APYX's debt has soared by 170% YoY
APYX's equity has dropped by 67% year-on-year and by 25% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.